ANTIFERTILITY EFFECT OF ORALLY FORMULATED MELATONIN TABLETS IN MICE

被引:8
|
作者
HAMED, MY
MOSTAFA, EM
TOUS, SS
机构
[1] UNIV ASSIUT,FAC PHARM,DEPT PHARMACEUT,ASSIUT,EGYPT
[2] UNIV ASSIUT,FAC MED,DEPT PHYSIOL,ASSIUT,EGYPT
关键词
MELATONIN; OVULATION; IMPLANTATION; MOLDED TABLET; POLYVINYLPYRROLIDONE; MICE; ANTIFERTILITY AGENT;
D O I
10.1016/0378-5173(91)90214-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Melatonin, a putative pineal hormone, has been proved to be active orally. In the present investigation the efficacy of melatonin as an oral antifertility agent in mice was investigated. Melatonin tablets prepared by the solvent deposition technique (SDT) were found to be superior in their physical properties and the release rate of melatonin from the tablets was higher than those prepared by the conventional mixing method (CMM). The interaction of melatonin with polyvinylpyrrolidone (PVP) and lactose may be responsible for its high release rate. Melatonin tablets prepared by the SDT were used to evaluate its antifertility effect in mice. This effect was compared with that of its intramuscular injection. Oral administration of melatonin on the proestrus day resulted in 100% reduction in the mean number of corpora lutea and lutein cells. The ovulation blockage ratio was 100%. The mean duration of the oestrus phase was significantly decreased. Absence of corpora lutea was evident histologically. On the 4th day of pregnancy, oral administration of melatonin led to 100% interruption of pregnancy and 100% reduction in the mean number of implantation sites. Also, the average number of the blood capillaries and their transverse diameter were significantly decreased. Histological examination of the interrupted pregnant uteri showed completely degenerated embryo. The result of oral administration of melatonin mimicked the known effects of its intramuscular injection.
引用
收藏
页码:93 / 102
页数:10
相关论文
共 50 条
  • [31] INVIVO EVALUATION OF COMMERCIAL AND FORMULATED CONVENTIONAL ASPIRIN TABLETS
    GADALLA, MAF
    ELHAMEED, MHA
    ISMAIL, AA
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (05) : 747 - 781
  • [32] DEGRADATION OF BISOPROLOL FUMARATE IN TABLETS FORMULATED WITH DICALCIUM PHOSPHATE
    DULIN, WA
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (04) : 393 - 409
  • [33] Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice
    Kim, Jeon-Kyung
    Choi, Min Sun
    Jeong, Jin-Ju
    Lim, Su-Min
    Kim, In Sook
    Yoo, Hye Hyun
    Kim, Dong-Hyun
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (02) : 122 - 130
  • [34] Development and evaluation of ofloxacin orally disintegrating tablets
    Mohite, Badrinath Pralhadrao
    Chafle, Sandip Annaji
    Somasundaram, Jayaprakash
    Avari, Jasmine Gev
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (02) : 217 - 225
  • [35] Treatment noncompliance with orally disintegrating olanzapine tablets
    Freudenreich, O
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (05): : 353 - 354
  • [36] Orally disintegrating tablets using starch and fructose
    Morales, Javier O.
    Horng, Michelle
    Gregg, Aubrey M.
    McConville, Jason T.
    Pharmaceutical Technology, 2010, 34 (11) : 92 - 99
  • [37] Formulation technologies of orally fast disintegrating tablets
    Bircan, Yagmur
    Comoglu, Tansel
    MARMARA PHARMACEUTICAL JOURNAL, 2012, 16 (02) : 77 - 81
  • [38] Taste masking microspheres for orally disintegrating tablets
    Xu, Jianchen
    Bovet, Li Li
    Zhao, Kang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 359 (1-2) : 63 - 69
  • [39] Formulation studies for mirtazapine orally disintegrating tablets
    Yildiz, Simay
    Aytekin, Eren
    Yavuz, Burcin
    Pehlivan, Sibel Bozdag
    Unlu, Nursen
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (06) : 1008 - 1017
  • [40] SUPERDISINTEGRANTS IN THE DEVELOPMENT OF ORALLY DISINTEGRATING TABLETS: A REVIEW
    Pahwa, Rakesh
    Gupta, Nisha
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (11): : 2767 - 2780